Results 1 to 10 of about 3,759,163 (248)

Ablative radiotherapy in castration-resistant prostate cancer. [PDF]

BJU Int
Hölscher T, Lohaus F, Koi L, Kotzerke J, Hoberück S, Thomas C, Borkowetz A, Löck S, Krause M, Troost EGC.   +9 more
europepmc   +1 more source

Modernizing disease assessment in prostate cancer trials: the Prostate Cancer Working Group 4 framework. [PDF]

Oncologist
Zugman M, Barata PC.
europepmc   +1 more source

Novel immunotherapies for prostate cancer. [PDF]

Urol Oncol
Mo G, Narayan V.
europepmc   +1 more source

A prostate cancer-specific super-enhancer at 1q42.3 regulates the CAPN2 and KRT19. [PDF]

J Biol Chem
Zhao Z, Bai Y, Wang Q, Zhao Y, Jiang Y, Li H, Yang Z, Liu X, Zhang L, Zhao Z, Qian Y, Li P, Shi J, Lu W.   +13 more
europepmc   +1 more source

The glycobiology of prostate cancer: an update. [PDF]

Oncogene
Hodgson K, Orozco-Moreno M, Peng Z, Blencoe L, Sharp MJ, Smith E, Grimsley G, Elliott DJ, Beatson R, Drake RR, Munkley J.   +10 more
europepmc   +1 more source

Editorial: Advances in combined modality treatments for prostate cancer. [PDF]

Front Surg
Sun F.
europepmc   +1 more source

Comparative assessment of METastasis Reporting and Data System for Prostate Cancer versus Prostate Cancer Clinical Trials Working Group 3 Criteria in assessing treatment response in patients with metastatic castration-resistant prostate cancer. [PDF]

Eur Urol Open Sci
Russo L, Longoria O, Bottazzi S, Porta N, Biscombe K, Withey SJ, Avesani G, Abramovicz K, Blackledge MD, D'Erme L, Russell-Rose K, Taha T, Sharp A, Paschalis A, Sala E, Koh DM, de Bono J, Tunariu N.   +17 more
europepmc   +1 more source

The Role of Artificial Intelligence in Optimizing Diagnosis in Prostate Cancer-A Narrative Review. [PDF]

J Clin Med
Rahota RG, Badulescu AV, Buhas BA, Moga M, Vaidean D, Popa A, Ploussard G.   +6 more
europepmc   +1 more source

Divergent evolution in bilateral prostate cancer: a case study. [PDF]

Front Oncol
Haas R, Huang RR, Weiner AB, Patel Y, Liu LY, Yamaguchi TN, Agrawal R, Boutros PC, Reiter RE.   +8 more
europepmc   +1 more source